Phase Angle Is a Potential Novel Early Marker for Sarcopenia and Cognitive Impairment in the General Population
Journal of Cachexia Sarcopenia and Muscle,
Journal Year:
2025,
Volume and Issue:
16(3)
Published: May 8, 2025
ABSTRACT
Background
Sarcopenia
is
associated
with
an
increased
risk
for
dementia.
This
study
aimed
to
elucidate
the
relationship
between
sarcopenia‐related
indices
and
cognitive
decline
in
general
population.
Methods
was
a
cross‐sectional
involving
263
participants
(163
men
median
age
of
60
years
[interquartile
range
=
53–70]
100
women
58
49–68])
who
underwent
health
examination.
Sarcopenia‐related
included
appendicular
skeletal
muscle
mass
(ASM)/height
2
,
ASM/body
index,
handgrip
strength
(HGS),
HGS/upper
extremity
phase
angle
(PhA).
We
examined
associations
these
function
using
Japanese
version
Montreal
Cognitive
Assessment
(MoCA‐J).
Results
Higher
PhA,
indicator
quality,
lower
mild
impairment
(MCI)
(adjusted
odds
ratio
0.28
[95%
confidence
interval,
0.10–0.78],
p
0.014),
whereas
other
showed
no
significant
association
MCI
both
sexes.
The
PhA
positively
MoCA‐J
scores
(
β
0.27,
0.005).
Moreover,
positive
correlation
subdomains,
including
memory
r
0.22,
0.031),
which
one
earliest
manifestations
impairment.
also
correlated
0.24,
0.002).
Conclusions
potentially
novel
index
detecting
sarcopenia
Language: Английский
Association between sarcopenia and healthy aging patterns among Chinese older adults: A latent class analysis approach
Geriatrics and gerontology international/Geriatrics & gerontology international,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 19, 2025
Background
From
the
perspective
of
active
aging,
understanding
relationship
between
sarcopenia
and
multidimensional
health
status
among
older
adults
is
crucial
for
developing
targeted
interventions
policies.
Methods
Data
were
derived
from
China
Health
Retirement
Longitudinal
Study
(CHARLS)
2018
survey.
In
total,
3392
(aged
≥60
years)
included
in
analysis.
Healthy
aging
was
assessed
using
38
items
across
seven
domains:
cognition,
psychological
symptoms,
vitality,
sensory
function,
mobility,
activities
daily
living
(ADLs),
instrumental
(IADLs).
Sarcopenia
evaluated
following
AWGS
2019
criteria.
Latent
class
analysis
performed
to
identify
distinct
patterns
healthy
logistic
regression
models
used
explore
patterns.
Results
identified
two
classes:
higher
(Class
1,
65.0%)
lower
2,
35.0%).
Older
with
different
types
negatively
associated
compared
those
without
sarcopenia.
Heterogeneity
analyses
revealed
that
≥70),
females
rural
residents
more
vulnerable
negative
impacts
on
aging.
Conclusion
Healthcare
providers
policymakers
should
develop
strategies
prevent
manage
while
promoting
adults.
Different
be
implemented
depending
sex
place
residence
Geriatr
Gerontol
Int
2025;
••:
••–••
.
Language: Английский
Evaluation of Sarcopenia screening indices as predictors of mortality in older patients with Alzheimer’s disease
Xinjie Song,
No information about this author
Sha Huang,
No information about this author
Mei Li
No information about this author
et al.
BMC Geriatrics,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Dec. 4, 2024
The
study
evaluated
the
effectiveness
of
sarcopenia
indices
neutrophils/lymphocytes,
platelets/lymphocytes,
AST/ALT,
and
creatinine
(Cr)/
cystatin
C
(CysC)*100
in
predicting
mortality
hospitalized
patients
with
Alzheimer's
disease
(AD)
aged
60
years
or
older.
This
retrospective
observational
survey
was
undertaken
a
teaching
hospital
western
China
from
January
1,
2017,
to
December
30,
2022.
neutrophil/lymphocyte,
platelet/lymphocyte,
Cr/CysC*100
ratios
were
used
assess
presence
sarcopenia,
upper
quartiles
as
cutoff
value.
Information
on
all-cause
obtained
through
telephone
interviews
electronic
medical
records
between
June
2024,
20,
2024.
Overall
survival
(OS)
represented
time
admission
death/final
follow-up.
Cox
proportional
hazards
models
applied
determine
relationships
above
parameters
all
causes.
information
523
AD
retrieved
record
system.
Of
these,
329
finally
enrolled,
whom
over
age
years.
use
Cr/Cys
C*100
indicator
found
be
effective
(24.39%
vs.
13.77%
for
those
without,
P
=
0.024).
However,
application
AST/ALT
indicators
showed
no
marked
differences
non-sarcopenia
participants.
After
further
logistic
regression
analysis
correction
possible
variables,
participants
had
an
increased
risk
death
relative
without
(HR
2.179,
95%CI:
1.175–4.044).
that
only
prediction
older
individuals
not
predictors.
Language: Английский